Advertisement
UK markets close in 10 minutes
  • FTSE 100

    7,964.64
    +32.66 (+0.41%)
     
  • FTSE 250

    19,898.31
    +87.65 (+0.44%)
     
  • AIM

    744.03
    +1.92 (+0.26%)
     
  • GBP/EUR

    1.1700
    +0.0031 (+0.27%)
     
  • GBP/USD

    1.2635
    -0.0003 (-0.03%)
     
  • Bitcoin GBP

    56,064.14
    +1,656.64 (+3.04%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,252.21
    +3.72 (+0.07%)
     
  • DOW

    39,784.54
    +24.46 (+0.06%)
     
  • CRUDE OIL

    82.53
    +1.18 (+1.45%)
     
  • GOLD FUTURES

    2,234.70
    +22.00 (+0.99%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,496.28
    +19.19 (+0.10%)
     
  • CAC 40

    8,213.59
    +8.78 (+0.11%)
     

This Big Pharma Stock Just Got an Upgrade. Is It Time to Buy?

This Big Pharma Stock Just Got an Upgrade. Is It Time to Buy?

Shares of Eli Lilly (NYSE: LLY) recently ticked higher in response to encouraging words from a Wall Street analyst who follows the pharmaceutical industry. Colin Bristow at UBS, an investment bank, thinks this is the most attractive pharma stock you can buy right now. Is Bristow right about Eli Lilly?